Search clinical trials for: Apalutamide
Total 107 results
-
Kindai UniversityJanssen Pharmaceutical K.K.RecruitingMetastatic Castration-sensitive Prostate CancerJapan
-
Aragon Pharmaceuticals, Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, Netherlands, United Kingdom, Moldova, Republic of
-
Aragon Pharmaceuticals, Inc.Active, not recruitingProstatic NeoplasmsUnited States, Australia, France, Poland, United Kingdom, Germany, Taiwan, Spain, Belgium, Israel, Romania, Japan, Canada, Denmark, Finland, Korea, Republic of, Netherlands, New Zealand, Russian Federation, Hungary, Austria, Sweden, Slovaki... and more
-
Edwin Posadas, MDEnviro Therapeutics, Inc.RecruitingCastration-resistant Prostate CancerUnited States
-
Janssen Research & Development, LLCWithdrawn
-
Janssen Research & Development, LLCRecruitingHepatic ImpairmentUnited States
-
Zhujiang HospitalRecruitingHigh-Risk and Oligometastatic Prostate CancerChina
-
BayerCompletedNon-metastatic Castration-resistant Prostate CancerUnited States
-
Westfälische Wilhelms-Universität MünsterJanssen Pharmaceutica N.V., BelgiumRecruitingProstatic NeoplasmsAustria, Germany
-
BayerActive, not recruitingNon-metastatic Castration-resistant Prostate CancerUnited States
-
Chinese University of Hong KongJanssen, LPTerminated
-
Janssen Research & Development, LLCCompleted
-
Singapore General HospitalCompletedCancer of the ProstateSingapore
-
Janssen Research & Development, LLCActive, not recruiting
-
Institut Paoli-CalmettesJanssen-Cilag Ltd.UnknownLow Risk Prostate CancerFrance
-
Aragon Pharmaceuticals, Inc.No longer availableProstatic NeoplasmsColombia, Brazil, Mexico
-
Janssen-Cilag Ltd.RecruitingMetastatic Hormone-sensitive Prostate CancerFrance, Germany, Spain, Greece, Austria, United Kingdom
-
Kangpu Biopharmaceuticals, Ltd.CompletedCastration-Resistant Prostate CancerUnited States
-
BayerActive, not recruiting
-
Universitaire Ziekenhuizen KU LeuvenUnknownProstate Cancer | Neoadjuvant Therapy | Prostatectomy | Androgen AntagonistsBelgium
-
CCTU- Cancer ThemeJanssen-Cilag Ltd.Completed
-
BayerCompletedNon-metastatic Prostate Cancer | Non-metastatic Castration-resistant Prostate CancerUnited States
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
Azienda Ospedaliero-Universitaria CareggiNot yet recruitingOligometastatic Hormone Sensitive Prostate CancerItaly
-
Cambridge University Hospitals NHS Foundation TrustUniversity of Cambridge; Janssen-Cilag Ltd.Recruiting
-
University of AthensWithdrawnProstatic Neoplasms, Castration-Resistant
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutica N.V., BelgiumRecruitingProstatic NeoplasmsBelgium, United States, Italy, Poland, Brazil, Denmark, Germany, Hungary, Mexico, Portugal, Russian Federation, Spain, Sweden, Turkey, Czechia, Finland, Austria, Australia, Lebanon, Slovakia, Jordan
-
Aragon Pharmaceuticals, Inc.Active, not recruitingProstatic NeoplasmsUnited States, France, Poland, Taiwan, Ukraine, United Kingdom, China, Belgium, Germany, Spain, Israel, Mexico, Malaysia, Romania, Turkey, Canada, Netherlands, Korea, Republic of, Brazil, Russian Federation, Argentina, Sweden, Czechia
-
Rahul AggarwalJanssen Scientific Affairs, LLCActive, not recruitingProstate Cancer | Small Cell Carcinoma | Small Cell Neuroendocrine CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteDendreonRecruitingProstate Cancer | Metastatic Prostate CancerUnited States
-
PfizerAstellas Pharma IncActive, not recruiting
-
University of California, San FranciscoJanssen PharmaceuticalsActive, not recruitingCastration-Resistant Prostate Carcinoma | PSA Progression | Stage IV Prostate Adenocarcinoma AJCC v7 | Castration Levels of TestosteroneUnited States
-
PfizerAstellas Pharma IncActive, not recruitingProstatic NeoplasmsUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteRecruitingProstate Cancer | Prostate Adenocarcinoma | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingProstate Adenocarcinoma | Stage IIB Prostate Cancer AJCC v8United States
-
M.D. Anderson Cancer CenterJanssen Scientific Affairs, LLCNot yet recruitingProstate Cancer | Prostatectomy | Androgen Axis SuppressionUnited States
-
Janssen Research & Development, LLCRecruitingMetastatic Castrate-sensitive Prostate CancerUnited States, France, Mexico, Germany, Australia, Brazil, Canada, China, Poland
-
University of WashingtonNational Cancer Institute (NCI); Janssen Scientific Affairs, LLCTerminatedProstate AdenocarcinomaUnited States
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Xian-Janssen Pharmaceutical Ltd.Not yet recruitingProstate Cancer | Biochemical Recurrence | High RiskChina
-
Janssen Research & Development, LLCCompleted
-
Qilu Hospital of Shandong UniversityRecruiting
-
Janssen Research & Development, LLCCompletedCastration-Resistant Prostatic NeoplasmsCanada, Belgium, United States, Spain, Netherlands, Italy, Russian Federation
-
UNC Lineberger Comprehensive Cancer CenterRecruiting
-
University of CincinnatiJanssen, LPRecruitingProstate CancerUnited States
-
Janssen Research & Development, LLCActive, not recruiting
-
National Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Localized Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8United States
-
Aragon Pharmaceuticals, Inc.Active, not recruitingProstate CancerUnited States, France, Poland, Ukraine, United Kingdom, China, Spain, Argentina, Israel, Mexico, Romania, Turkey, Korea, Republic of, Japan, Sweden, Canada, Russian Federation, Brazil, Germany, Hungary, Czechia, Australia
-
Zhujiang HospitalRecruitingProstate Cancer With ≤10 Bone MetastasesChina
-
National Cancer Institute (NCI)Not yet recruitingNon-Muscle Invasive Bladder Urothelial Carcinoma | Recurrent Non-Muscle Invasive Bladder Urothelial CarcinomaUnited States